EUVIMEDEUVIMED entdecken
Leserbrief

Beyond HER2 ‐Negative: Clinical and Molecular Relevance of HER2 ‐Ultralow Expression in Gynecologic Pathology

Gunvanti Rathod iD, Pragnesh Parmar iD

Journal of Obstetrics and Gynaecology Research · 2026-04 · 52 (4)

DOI: 10.1111/jog.70277 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Journal of Obstetrics and Gynaecology Research, online erschienen am 13.04.2026. Verfasst von Gunvanti Rathod und 1 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Department, AIIMS, Bibinagar, Telangana, India. Die Arbeit nennt 4 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Pathology Department, AIIMS, Bibinagar, Telangana, India.
  • FMT Department, AIIMS, Bibinagar, Telangana, India.

ORCID-Profile: Gunvanti Rathod, Pragnesh Parmar

Zitieren

APA

Rathod, G., & Parmar, P. (2026). Beyond HER2 ‐Negative: Clinical and Molecular Relevance of HER2 ‐Ultralow Expression in Gynecologic Pathology. Journal of Obstetrics and Gynaecology Research, 52(4). https://doi.org/10.1111/jog.70277

Vancouver

Rathod G, Parmar P. Beyond HER2 ‐Negative: Clinical and Molecular Relevance of HER2 ‐Ultralow Expression in Gynecologic Pathology. Journal of Obstetrics and Gynaecology Research. 2026;52(4). doi:10.1111/jog.70277

BibTeX
@article{Rathod2026,
  author = {Rathod, Gunvanti and Parmar, Pragnesh},
  title = {Beyond HER2 ‐Negative: Clinical and Molecular Relevance of HER2 ‐Ultralow Expression in Gynecologic Pathology},
  journal = {Journal of Obstetrics and Gynaecology Research},
  year = {2026},
  volume = {52},
  number = {4},
  doi = {10.1111/jog.70277}
}
Kostenlos starten →